Entag, Lorna G.
HRN: 29-08-39 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2026
CEFTRIAXONE 1G (VIAL)
05/31/2026
06/07/2026
IVTT
2g
OD
INFECTED WOUND
Checking Initial Appropriateness
05/31/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/31/2026
06/07/2026
IVTT
600mg
Q8H
INFECTED WOUND
Checking Initial Appropriateness
06/02/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/02/2026
06/09/2026
IV
4.5g
Q6
Dm Foot
Checking Initial Appropriateness